Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pathology of breast carcinoma: diagnostic, prognostic, and therapeutic issues and challenges.

Bhargava R, Sahoo S, Esposito NN, Chen B.

Patholog Res Int. 2011;2011:731470. doi: 10.4061/2011/731470. Epub 2011 Sep 25. No abstract available.

2.
3.

Borderline breast lesions: diagnostic challenges and clinical implications.

Masood S, Rosa M.

Adv Anat Pathol. 2011 May;18(3):190-8. doi: 10.1097/PAP.0b013e31821698cc. Review.

PMID:
21490436
4.

Changes in breast cancer therapy because of pathology second opinions.

Staradub VL, Messenger KA, Hao N, Wiley EL, Morrow M.

Ann Surg Oncol. 2002 Dec;9(10):982-7.

PMID:
12464590
5.

Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.

Tunon-de-Lara C, André G, Macgrogan G, Dilhuydy JM, Bussières JE, Debled M, Mauriac L, Brouste V, de Mascarel I, Avril A.

Ann Surg Oncol. 2011 May;18(5):1372-9. doi: 10.1245/s10434-010-1441-1. Epub 2010 Nov 25.

PMID:
21108045
6.

Mucinous breast lesions: diagnostic challenges.

Tan PH, Tse GM, Bay BH.

J Clin Pathol. 2008 Jan;61(1):11-9. Epub 2007 Sep 14. Review.

PMID:
17873114
7.

Breast screening in Singapore: implications for pathology.

Tan PH.

Ann Acad Med Singapore. 2007 Oct;36(10):827-33. Review.

8.

Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 cases. The Association for Research in Oncologic Gynecology.

Bonnier P, Body G, Bessenay F, Charpin C, Fétissof F, Beedassy B, Lejeune C, Piana L.

Eur J Obstet Gynecol Reprod Biol. 1999 May;84(1):27-35.

PMID:
10413223
9.

Challenges in the interpretation of breast core biopsies.

Corben AD, Edelweiss M, Brogi E.

Breast J. 2010 Sep-Oct;16 Suppl 1:S5-9. doi: 10.1111/j.1524-4741.2010.00993.x.

PMID:
21050312
10.
11.

Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.

Coleman JF, Hansel DE.

Adv Anat Pathol. 2009 Mar;16(2):67-78. doi: 10.1097/PAP.0b013e318199f89e. Review.

PMID:
19550368
12.

Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia.

Harvey JM, Sterrett GF, McEvoy S, Fritschi L, Jamrozik K, Ingram D, Joseph D, Dewar J, Byrne MJ; Key Cancers Patterns of Care Study Group.

Pathology. 2005 Oct;37(5):341-6.

PMID:
16194843
13.

Papillary lesions of the breast: selected diagnostic and management issues.

Collins LC, Schnitt SJ.

Histopathology. 2008 Jan;52(1):20-9. doi: 10.1111/j.1365-2559.2007.02898.x. Review.

PMID:
18171414
15.

[Male breast carcinoma: prognostic and predictive factors related to biological behavior].

Luque EH, Muñoz de Toro M.

Medicina (B Aires). 1998;58(1):95-105. Review. Spanish.

PMID:
9674215
16.

[Basal-like carcinoma of the breast--the actual review and clinico-pathological corelations].

Kinkor Z.

Ceska Gynekol. 2007 Oct;72(5):351-4. Review. Czech.

PMID:
18175520
17.

Image cytometric analysis in pathology.

Cohen C.

Hum Pathol. 1996 May;27(5):482-93.

PMID:
8621187
18.

Primary squamous cell carcinoma of the breast.

Brack K, Ramaekers PC, Tjalma WA.

Eur J Gynaecol Oncol. 2003;24(5):384-6.

PMID:
14584651
19.

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.

Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GN.

Cancer. 2003 Sep 15;98(6):1150-60. Review.

20.

[Molecular biology of breast carcinoma. Current diagnostic, therapeutic and prognostic aspects].

Schwarz LE, Schlag PM.

Zentralbl Chir. 1998;123 Suppl 5:6-12. Review. German.

PMID:
10063562
Items per page

Supplemental Content

Write to the Help Desk